Zygomycete infection following voriconazole prophylaxis

Lancet Infect Dis. 2005 Sep;5(9):594. doi: 10.1016/S1473-3099(05)70220-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antifungal Agents / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Drug Resistance, Fungal
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy
  • Male
  • Microbial Sensitivity Tests
  • Pyrimidines / therapeutic use*
  • Rhizopus / drug effects
  • Rhizopus / growth & development
  • Triazoles / therapeutic use*
  • Voriconazole
  • Zygomycosis / drug therapy
  • Zygomycosis / prevention & control*

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Pyrimidines
  • Triazoles
  • Voriconazole